Paul Sargeant is the President and Chief Executive Officer of Circular Genomics. He has a 25-year global career, having worked in US, Europe, and Asia with Fortune 100 and venture-backed start-ups at the intersection between science and technology and its productization, approval, launch, and commercialization through to exits. He has a PhD in physiology from Queens’ College Cambridge, UK.